Free Trial

Jefferies Financial Group Inc. Purchases New Position in Cushman & Wakefield plc (NYSE:CWK)

Cushman & Wakefield logo with Finance background

Jefferies Financial Group Inc. bought a new position in Cushman & Wakefield plc (NYSE:CWK - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 191,000 shares of the company's stock, valued at approximately $2,498,000. Jefferies Financial Group Inc. owned 0.08% of Cushman & Wakefield as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its stake in Cushman & Wakefield by 6.3% during the 4th quarter. JPMorgan Chase & Co. now owns 13,700,599 shares of the company's stock valued at $179,204,000 after purchasing an additional 806,684 shares during the period. Vaughan Nelson Investment Management L.P. grew its position in shares of Cushman & Wakefield by 9.6% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 12,474,380 shares of the company's stock valued at $163,164,000 after purchasing an additional 1,094,260 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Cushman & Wakefield by 6.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 11,586,407 shares of the company's stock worth $151,551,000 after purchasing an additional 736,955 shares during the last quarter. Channing Capital Management LLC bought a new position in Cushman & Wakefield during the fourth quarter valued at approximately $61,732,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in Cushman & Wakefield by 1.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,027,744 shares of the company's stock valued at $52,683,000 after buying an additional 52,178 shares in the last quarter. 95.56% of the stock is currently owned by hedge funds and other institutional investors.

Cushman & Wakefield Stock Down 1.3%

Shares of CWK traded down $0.14 during mid-day trading on Monday, hitting $10.42. The company's stock had a trading volume of 136,637 shares, compared to its average volume of 2,127,120. The company's 50-day moving average is $9.60 and its 200-day moving average is $12.11. The company has a current ratio of 1.15, a quick ratio of 1.18 and a debt-to-equity ratio of 1.67. The firm has a market capitalization of $2.41 billion, a price-to-earnings ratio of 18.95 and a beta of 1.37. Cushman & Wakefield plc has a 52-week low of $7.64 and a 52-week high of $16.11.

Cushman & Wakefield (NYSE:CWK - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.02 by $0.07. Cushman & Wakefield had a net margin of 1.39% and a return on equity of 12.62%. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.26 billion. The firm's revenue was up 4.6% on a year-over-year basis. On average, equities research analysts forecast that Cushman & Wakefield plc will post 1.2 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CWK shares. JPMorgan Chase & Co. decreased their price target on shares of Cushman & Wakefield from $17.00 to $14.00 and set a "neutral" rating on the stock in a research note on Thursday, April 10th. The Goldman Sachs Group lowered their price objective on Cushman & Wakefield from $13.00 to $11.50 and set a "sell" rating for the company in a research note on Wednesday, March 19th. UBS Group cut their target price on Cushman & Wakefield from $14.00 to $9.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Citigroup lowered their price target on Cushman & Wakefield from $16.00 to $12.00 and set a "neutral" rating for the company in a research report on Monday, March 17th. Finally, Morgan Stanley dropped their price objective on shares of Cushman & Wakefield from $15.00 to $14.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Cushman & Wakefield has an average rating of "Hold" and a consensus target price of $12.93.

View Our Latest Stock Analysis on CWK

Cushman & Wakefield Profile

(Free Report)

Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.

Featured Stories

Institutional Ownership by Quarter for Cushman & Wakefield (NYSE:CWK)

Should You Invest $1,000 in Cushman & Wakefield Right Now?

Before you consider Cushman & Wakefield, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman & Wakefield wasn't on the list.

While Cushman & Wakefield currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines